Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab

The introduction of biologics for the treatment of patients with refractory asthma represented a marked therapeutic advance. For more than 10 y, the only biologic available has been the monoclonal anti-IgE antibody omalizumab, reserved for patients with asthma caused by perennial allergen. In recent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Erminia Ridolo (Autor), Francesco Pucciarini (Autor), Maria Cristina Nizi (Autor), Eleni Makri (Autor), Paola Kihlgren (Autor), Lorenzo Panella (Autor), Cristoforo Incorvaia (Autor)
Formato: Livro
Publicado em: Taylor & Francis Group, 2020-10-01T00:00:00Z.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Connect to this object online.

3rd Floor Main Library

Detalhes do Exemplar 3rd Floor Main Library
Número de Chamada: A1234.567
Cópia 1 Disponível